Candriam Equities L Oncology Impact I/ LU1864482515 /
| NAV2024-05-15 | Chg.+14.5801 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,253.8301GBP | +0.65% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 2024-05-17 | Public WebStation Live Factsheet | 2024 | English | - |
| 2024-03-01 | PRIIP Key Information Document | 2024 | English | 261.95 KB |
| 2024-03-01 | PRIIP Key Information Document | 2024 | German | 269.00 KB |
| 2023-12-31 | Account statment | 2023 | English | 5,416.37 KB |
| 2023-12-31 | Account statment | 2023 | German | 4,732.66 KB |
| 2023-09-11 | Prospectus | 2023 | English | 3,638.77 KB |
| 2023-09-11 | Prospectus | 2023 | German | 3,801.35 KB |
| 2023-06-30 | Semi-annual report | 2023 | English | 1,982.78 KB |
| 2023-06-30 | Semi-annual report | 2023 | German | 2,086.39 KB |
| 2022-07-02 | Key Investor Information | 2022 | English | 292.88 KB |
| 2022-07-02 | Key Investor Information | 2022 | German | 359.88 KB |
